🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To assess the efficacy and safety of Abatacept as an immunosuppressive trea...
Status
Completed
Location
UZLeuven
Start Date
2019-04-01
Trial ID
NCT03871361
Treatments Being Tested
The purpose of this study is to assess the efficacy, pharmacokinetics, safe...
Status
Completed
Location
Local Institution
Start Date
2009-12
Trial ID
NCT01001832
Treatments Being Tested
This study is conducted to evaluate the short (12 Weeks) and long term (104...
Status
Completed
Location
141
Start Date
2011-12
Trial ID
NCT01500278
Treatments Being Tested
The purpose of this study is to asses the long term efficacy, safety and im...
Status
Unknown
Location
Instituto Medico CER
Start Date
2016-10-06
Trial ID
NCT03403140
Treatments Being Tested
Primary Objective: To evaluate the efficacy of sarilumab at Week 16 in par...
Status
Completed
Location
Investigational Site Number 840008
Start Date
2013-10
Trial ID
NCT01900431
Treatments Being Tested
Dactylitis is a poor prognostic factor in psoriatic arthritis (PsA) patient...
Status
Completed
Location
Centro Académico de Medicina de Lisboa
Start Date
2014-08
Trial ID
NCT02065713
Treatments Being Tested
The purpose of the study is to better understand the factors present in the...
Status
Completed
Location
Outpatient Care Center
Start Date
2015-08
Trial ID
NCT02451748
The primary objective of this study is to assess the number of patients pre...
Status
Completed
Location
Kerckhoff Clinic
Start Date
2012-07
Trial ID
NCT01793259
Treatments Being Tested
The purpose of this 2 phased, open-label study is to compare the safety and...
Status
Completed
Location
Investigaciones Reumatológicas y Osteológicas
Start Date
2009-06
Trial ID
NCT00848354
The study aims to evaluate the predictability of early response to Certoliz...
Status
Completed
Location
11
Start Date
2011-12
Trial ID
NCT01443364
Treatments Being Tested